The Windsor Framework – SPC implications

Dr. Beatriz San Martin, Arnold & Porter

Dr. Beatriz San Martin has extensive experience in intellectual property matters with a particular focus on innovative and emerging technologies, particularly within the life sciences sector, as well as technology enabled solutions. She is sought after for her strategic input on the interplay and enforcement of intellectual property rights and trade secrets, her niche SPC experience, and her specialist knowledge of international treaties relating to genomic resources such as the Nagoya Protocol.

Her disputes practice is varied with significant and high-profile experience handling cases before the UK Courts and the Court of Justice of the European Union, coordinating cross-border European litigation and assisting in multinational arbitrations. She robustly manages and resolves disputes relating to the full spectrum of intellectual property rights, assists clients on challenging technical issues and provides strategic IP advice.

Prior to pursuing a legal career, Beatriz was a scientist with a degree, Ph.D. and postdoc specialising in genetics, cellular and molecular biology. This interest and passion in science and technology has broadened during the course of her legal career through her varied work with clients and involvement in trade associations.

Jacqueline Mulryne, Arnold & Porter

Jackie Mulryne is a member of the Life Sciences practice group, and provides regulatory, policy and compliance advice to clients in the pharmaceutical, medical technology, cosmetics and foods sectors. She advises on complex regulatory issues that arise throughout the product life cycle, including maximising regulatory protections and the overlap with IP rights, borderline classification, clinical research, authorisation, advertising and promotion, and market access strategy. She regularly develops strategies to help bring innovative products to market, and helps companies develop and implement cross-border regulatory compliance programmes.

Ms. Mulryne also assists life sciences and technology companies navigate the medical devices and in vitro diagnostic regulatory frameworks, and in particular advises companies on launching digital health and AI technologies.

Ms. Mulryne specialises in contentious disputes in the sector, and has extensive experience in public and administrative law litigation, in assisting clients with sensitive internal investigations and regulatory inspections, and in defending enforcement actions by the competent authorities. She also coordinates such matters across Europe. She advises on a wide range of actions arising from the decisions of regulatory bodies, and represents clients challenging public procurement tenders.

Ms. Mulryne also works on product liability matters on behalf of pharmaceutical and medical device companies, and has assisted on large multiparty actions, and in defending individual personal injury and product liability claims.

Ms. Mulryne is committed to pro bono work, and has acted for a number of organisations and individuals before the UK and international courts.